Single High Dose Vitamin C, E in Severe Birth Asphyxia

This study has been completed.
Information provided by (Responsible Party):
Jayendra R. Gohil, Sir Takhtasinhji General Hospital Identifier:
First received: November 29, 2012
Last updated: December 4, 2012
Last verified: December 2012

To study the role of single high dose vitamin E and vitamin C in hypoxic ischemic encephalopathy in newborns, in reduction of morbidity and adverse neurodevelopmental sequelae.

Condition Intervention Phase
Birth Asphyxia
Drug: Vitamin E, Vitamin C
Phase 4

Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Single High Dose Vitamin E and Vitamin C in Hypoxic Ischemic Encephalopathy (Following Birth Asphyxia)in Newborns

Resource links provided by NLM:

Further study details as provided by Sir Takhtasinhji General Hospital:

Primary Outcome Measures:
  • To assess the role of single high dose vitamin E and vitamin C in reduction of adverse neurodevelopmental sequelae in newborns with birth asphyxia. [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Mortality and morbidity in newborns with birth asphyxia administered vitamin E and vitamin C. [ Time Frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 15 DAYS. ] [ Designated as safety issue: No ]

Other Outcome Measures:
  • Role of single high dose vitamin E and vitamin C in progression or resolution of Hypoxic ischemic encephalopathy. [ Time Frame: at 12 hours ] [ Designated as safety issue: No ]
  • Role of single high dose vitamin E and vitamin C in progression or resolution of Hypoxic ischemic encephalopathy. [ Time Frame: 15 days ] [ Designated as safety issue: No ]

Enrollment: 95
Study Start Date: April 2012
Study Completion Date: October 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Oral vitamin E, vitamin C
Single dose of vitamin E drops 200 IU within 6 hours of birth and vitamin C tablet 250 mg in pulverised form (2 doses at 24 hr interval) via infant feeding tube
Drug: Vitamin E, Vitamin C
Other Names:
  • Evion drops
  • Tablet Limcee


Ages Eligible for Study:   up to 6 Hours
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria

  1. Apgar score of <6 at 5 minutes
  2. Clinical features suggestive of neonatal encephalopathy (coma, seizures or hypotonia)

Exclusion Criteria

  1. Newborn hospitalized in neonatal intensive care unit (NICU) after 6 hours of birth
  2. Gestational age <32 weeks.
  3. Lethal congenital anomaly
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01743742

NICU, Sir T Hospital, Bhavnagar
Bhavnagar, Gujarat, India, 364002
Sponsors and Collaborators
Sir Takhtasinhji General Hospital
Principal Investigator: Jayendra R Gohil, MD Professor of Pediatrics, Dept of Pediatrics, Govt Medical College, Bhavnagar, Gujarat, India
  More Information

Responsible Party: Jayendra R. Gohil, Professor of Pediatrics, Sir Takhtasinhji General Hospital Identifier: NCT01743742     History of Changes
Other Study ID Numbers: Antioxidants in Birth Asphyxia
Study First Received: November 29, 2012
Last Updated: December 4, 2012
Health Authority: India: Institutional Review Board

Keywords provided by Sir Takhtasinhji General Hospital:
Oral vitamin E and vitamin C

Additional relevant MeSH terms:
Asphyxia Neonatorum
Brain Ischemia
Hypoxia-Ischemia, Brain
Pathologic Processes
Wounds and Injuries
Infant, Newborn, Diseases
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Hypoxia, Brain
Ascorbic Acid
Vitamin E
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protective Agents
Physiological Effects of Drugs
Growth Substances processed this record on August 19, 2014